- Health Economics
- Health Technology Assessment (HTA)
- Dressings and securements for the prevention of peripheral intravenous catheter failure in adults (SAVE): a pragmatic, randomised controlled, superiority trial
- El-Saifi, N., Moyle, W., Jones, C., & Tuffaha, H. (2018). Medication Adherence in Older Patients with Dementia: A Systematic Literature Review. Journal of Pharmacy Practice, 31(3), 322–334.
- Gordon, L. G., Tuffaha, H., James, R., Keller, A. T., Lowe, A., Scuffham, P., & Gardiner, R. A. (2018). Estimating the healthcare costs of treating prostate cancer in Australia: A Markov modelling analysis. Urologic Oncology: Seminars and Original Investigations, 36(3), 91–e7–91–e15.
- Tuffaha, H., & Scuffham, P. (2018). The Australian Managed Entry Scheme: Are We Getting it Right? PharmacoEconomics, 36(5), 555–565.
- Tuffaha, H., Marsh, N., Byrnes, J., Gavin, N., Webster, J., Cooke, M., & Rickard, C. (2018). Cost of vascular access devices in public hospitals in Queensland. Australian Health Review, 1–5.
- Tuffaha, H., Mitchell, A., Ward, R. L., Connelly, L., Butler, J. R. G., Norris, S., & Scuffham, P. (2018). Cost-effectiveness analysis of germ-line BRCA testing in women with breast cancer and cascade testing in family members of mutation carriers. Genetics in Medicine, 20(9), 985–994.
- Nazer, L. H., & Tuffaha, H. (2017). Health Care and Pharmacy Practice in Jordan. Canadian Journal of Hospital Pharmacy, 70(2), 150–155.
- Tuffaha, H., Andronis, L., & Scuffham, P. (2017). Setting Medical Research Future Fund priorities: assessing the value of research. Medical Journal of Australia, 206(2), 64–65.
- Ball, L., Lee, P., Ambrosini, G., Hamilton, K., & Tuffaha, H. (2016). How often should general practitioners provide nutrition care to patients? A forecasting activity to determine the target frequency for chronic-disease management in Australia. Australian Journal of Primary Health, 22(5), 383–387.
- El-Saifi, N., Moyle, W., Jones, C., & Tuffaha, H. (2016). Quetiapine safety in older adults: a systematic literature review. Journal of Clinical Pharmacy and Therapeutics, 41(1), 7–18.
- Gordon, L., James, R., Tuffaha, H., Lowe, A., & Yaxley, J. (2016). Cost-effectiveness analysis of multiparametric MRI with increased active surveillance for low-risk prostate cancer in Australia. Journal of Magnetic Resonance Imaging, 1–12.
- Nazer, L. H., Tuffaha, H., & Jaddoua, S. (2016). A Program to Increase Research Productivity Among Hospital Pharmacists. Journal of Pharmacy Practice, 1–6.
- Tuffaha, H. (2016). Value of Information Analysis Applications in Healthcare Interventions.
- Tuffaha, H., Roberts, S., Chaboyer, W., Gordon, L., & Scuffham, P. (2016). Cost-effectiveness Analysis of Nutritional Support for the Prevention of Pressure Ulcers in High-Risk Hospitalized Patients. Advances in Skin & Wound Care, 29(6), 261–267.
- Tuffaha, H., Strong, M., Gordon, L., & Scuffham, P. (2016). Efficient Value of Information Calculation Using a Nonparametric Regression Approach: An Applied Perspective. Value in Health, 19(4), 505–509.
- Reynolds, H., Taraporewalla, K., Tower, M., Mihala, G., Tuffaha, H., Fraser, J., & Rickard, C. (2015). Novel technologies can provide effective dressing and securement for peripheral arterial catheters: A pilot randomised controlled trial in the operating theatre and the intensive care unit. Australian Critical Care, 28(3), 140–148.
- Tuffaha, H., Gillespie, B., Chaboyer, W., Gordon, L., & Scuffham, P. (2015). Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds. Journal of Surgical Research, 195(2), 612–622.
- Tuffaha, H., Roberts, S., Chaboyer, W., Gordon, L., & Scuffham, P. (2015). Cost-Effectiveness and Value of Information Analysis of Nutritional Support for Preventing Pressure Ulcers in High-risk Patients: Implement Now, Research Later. Applied Health Economics and Health Policy, 13(2), 167–179.
- Tuffaha, H., Gordon, L., & Scuffham, P. (2014). Value of information analysis in healthcare: a review of principles and applications. Journal of Medical Economics, 17(6), 377–383.
- Tuffaha, H., Reynolds, H., Gordon, L., Rickard, C., & Scuffham, P. (2014). Value of information analysis optimizing future trial design from a pilot study on catheter securement devices. Clinical Trials, 1–9.
- Tuffaha, H., Rickard, C., Inwood, S., Gordon, L., & Scuffham, P. (2014). The epic3 recommendation that clinically indicated replacement of peripheral venous catheters is safe and cost-saving: how much would the NHS save? Journal of Hospital Infection, 87(3), 183–184.
- Tuffaha, H., Rickard, C., Webster, J., Marsh, N., Gordon, L., Wallis, M., & Scuffham, P. (2014). Cost-effectiveness analysis of clinically-indicated versus routine replacement of peripheral intravenous catheters. Applied Health Economics and Health Policy, 12(1), 51–58.
- Abdel-Rahman, F., Tuffaha, H., Sharma, S., Jazar, H. A., Hussein, N., Saad, A., … Hussein, A. (2013). GCSF with or without chemotherapy compared to Plerixafor with GCSF as salvage mobilization regimen in patients with multiple myeloma and lymphoma: Collection effectiveness and cost effectiveness analysis. Journal of Oncology Pharmacy Practice, 1–7.
- Tuffaha, H., Gordon, L., & Scuffham, P. (2013). Value of Information Analysis in Oncology: The Value of Evidence and Evidence of Value. Journal of Oncology Practice, 1–8.
- Salmany, S. S., Koopmans, S. M., Treish, I. M., Jaber, R., Telfah, S., & Tuffaha, H. (2012). Revision and Validation of a Medication Assessment Tool for Chronic Cancer Pain Management. American Journal of Hospice and Paliative Care, 29(8), 640–646.
- Tuffaha, H., & Koopmans, S. (2012). Development and implementation of a method for characterizing clinical pharmacy interventions and medication use in a cancer center. Journal of Oncology Pharmacy Practice, 18(2), 180–185.
- Tuffaha, H., & Omar, S. A. (2012). Glucarpidase for the treatment of life-threatening methotrexate overdose. Drugs of Today, 48(11), 705–711.
- Tuffaha, H., Abdelhadi, O., & Omar, S. (2012). Clinical pharmacy services in the outpatient pediatric oncology clinics at a comprehensive cancer center. International Journal of Clinical Pharmacy, 34(1), 27–31.
- Tuffaha, H., & Omar, S. (2011). Glucarpidase rescue in a patient with high-dose methotrexate-induced nephrotoxicity. Journal of Oncology Pharmacy Practice, 17(2), 136–140.
- Tuffaha, H., & Abdel-Rahman, F. A.-L. (2010). Successful stem-cell mobilization and transplantation using plerixafor in a patient with a germ cell tumor. Hematology/Oncology and stem cell therapy., 3(4), 203–205.
- Tuffaha, H., Treish, I., & Zaru, L. (2008). The use and effectiveness of granulocyte colony-stimulating factor in primary prophylaxis for febrile neutropenia in the outpatient setting. Journal of Oncology Pharmacy Practice, 14(3), 131–138.
Dr Haitham Tuffaha is a Senior Research Fellow in Health Economics and an NHMRC
Fellow at the Centre for Applied Health Economics, School of Medicine, Griffith University.
Haitham has over five years of experience in Health Technology Assessment as an
evaluator of Pharmaceutical Benefits Advisory Committee (PBAC) and Medical Services Advisory Committee (MSAC) submissions for the Australian Government.
His research is centered on the economic evaluation of health care interventions. He has interest in Value of Information analysis as an approach to improve early access to novel cancer drugs via managed entry agreements. Furthermore, he is leading a project to develop a practical value of information-based tool to inform research funding and prioritisation decisions.
Before joining Griffith University, Haitham had ten years of experience as clinical pharmacy specialist and manager with proven record of leadership and mentoring. He was Head of Clinical Pharmacy at King Hussein Cancer Center. In that position, He supervised a team of 15 clinical pharmacists covering various inpatient and ambulatory services ensuring safe, effective and cost-effective use of medicines.
Haitham holds a PhD in Health Economics from Griffith University, an MSc in Clinical
Pharmacy with Distinction from Strathclyde University in Glasgow, and an MBA from
Wollongong University. He is also a Board-Certified Oncology Specialist by the Board of Pharmacy Specialties, USA. He holds prestigious awards for his achievements in practice and research including Griffith University Vice Chancellor and Pro-Vice Chancellor Research Excellence Awards, the Endeavour Executive Award, and AusHSI Best Health Services Research Award.
Haitham chairs the Clinical Oncology Society of Australia (COSA) Epidemiology Group, and he is a Committee Member of ISPOR-Australia Chapter.
Haitham has an excellent record of international presentations and publications with almost 50 papers and technical reports. In addition, he is an Editorial Board Member of PharmacoEconomics-Open journal.
Editorial Board Member, PharmacoEconomics-Open 2016 -
BPharm Pharmacist, JU -
MBA Superviosr, DAD -
MSc (clinical pharmacy) Clinical Pharmacist, KHCC -
PhD Senior Research Fellow, Griffith University -